HRP20190026T1 - Testovi za određivanje prisutnosti ili količine protutijela protiv lijeka - Google Patents

Testovi za određivanje prisutnosti ili količine protutijela protiv lijeka

Info

Publication number
HRP20190026T1
HRP20190026T1 HRP20190026TT HRP20190026T HRP20190026T1 HR P20190026 T1 HRP20190026 T1 HR P20190026T1 HR P20190026T T HRP20190026T T HR P20190026TT HR P20190026 T HRP20190026 T HR P20190026T HR P20190026 T1 HRP20190026 T1 HR P20190026T1
Authority
HR
Croatia
Prior art keywords
assays
detecting
amount
drug antibody
antibody
Prior art date
Application number
HRP20190026TT
Other languages
English (en)
Inventor
Ryan GRABERT
Susan Richards
Valerie THEOBALD
Yuanxin Xu
Jad ZOGHBI
Original Assignee
Genzyme Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corporation filed Critical Genzyme Corporation
Publication of HRP20190026T1 publication Critical patent/HRP20190026T1/hr

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/539Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2430/00Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
HRP20190026TT 2014-02-11 2019-01-03 Testovi za određivanje prisutnosti ili količine protutijela protiv lijeka HRP20190026T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461938556P 2014-02-11 2014-02-11
PCT/US2015/015442 WO2015123315A1 (en) 2014-02-11 2015-02-11 Assays for detecting the presence or amount of an anti-drug antibody
EP15710304.5A EP3105592B1 (en) 2014-02-11 2015-02-11 Assays for detecting the presence or amount of an anti-drug antibody

Publications (1)

Publication Number Publication Date
HRP20190026T1 true HRP20190026T1 (hr) 2019-02-22

Family

ID=52684652

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20190026TT HRP20190026T1 (hr) 2014-02-11 2019-01-03 Testovi za određivanje prisutnosti ili količine protutijela protiv lijeka

Country Status (19)

Country Link
US (3) US9759732B2 (hr)
EP (4) EP3105592B1 (hr)
CN (1) CN106164670B (hr)
AU (2) AU2015217261B2 (hr)
CA (1) CA2939080A1 (hr)
CY (1) CY1121341T1 (hr)
DK (1) DK3105592T3 (hr)
ES (1) ES2705403T3 (hr)
HR (1) HRP20190026T1 (hr)
HU (1) HUE041669T2 (hr)
LT (1) LT3105592T (hr)
MX (2) MX2016010413A (hr)
PL (1) PL3105592T3 (hr)
PT (1) PT3105592T (hr)
RS (1) RS58212B1 (hr)
SG (2) SG11201606291VA (hr)
SI (1) SI3105592T1 (hr)
TR (1) TR201900160T4 (hr)
WO (1) WO2015123315A1 (hr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3105592T3 (pl) 2014-02-11 2019-04-30 Genzyme Corp Testy do wykrywania obecności lub ilości przeciwciała antylekowego
EP2982987A1 (en) * 2014-08-08 2016-02-10 Proteomika, S.L. Lateral flow immunoassays for the detection of antibodies against biological drugs
US9927443B2 (en) * 2015-04-10 2018-03-27 Conquerab Inc. Risk assessment for therapeutic drugs
MX2018004322A (es) * 2015-10-15 2018-11-09 Biocon Ltd Metodo para detectar anticuerpos neutralizantes contra la insulina mana recombinante en suero mano.
CN108369227B (zh) * 2015-12-16 2021-07-16 豪夫迈·罗氏有限公司 三步酸解离酶联免疫吸附(tadelis)测定法
US9903866B2 (en) 2016-04-05 2018-02-27 Conquerab Inc. Portable devices for detection of antibodies against therapeutic drugs
EP3239711B1 (en) * 2016-04-27 2019-12-25 JIMRO Co., Ltd. Method for measuring anti-drug antibody
WO2019030202A1 (en) * 2017-08-08 2019-02-14 F. Hoffmann-La Roche Ag METHOD FOR DETECTION OF ANTI-MEDICATION ANTIBODIES IN A MINI-PORK SAMPLE
KR102551444B1 (ko) * 2017-11-29 2023-07-06 에프. 호프만-라 로슈 아게 표적 간섭이 억제된 항-약물 항체 분석
CN109358192B (zh) * 2018-02-08 2020-05-12 中国科学院上海药物研究所 一种去除抗药抗体检测样品中游离药物的装置和方法、该装置的制备方法及应用
IL277890B2 (en) * 2018-04-11 2024-03-01 Regeneron Pharma Methods for quantification of IL-33
EP3821255A1 (en) * 2018-07-10 2021-05-19 Regeneron Pharmaceuticals, Inc. Methods for mitigating drug target interference in an anti-drug antibody (ada) immunoassay
CN112534263A (zh) * 2018-08-03 2021-03-19 百时美施贵宝公司 用于检测抗药抗体的方法
US20200333331A1 (en) * 2019-04-16 2020-10-22 Laboratory Corporation Of America Holdings Methods and Systems for Detecting Antibodies by Surface Plasmon Resonance
KR20200124556A (ko) 2019-04-24 2020-11-03 삼성전자주식회사 펠리클 조립체의 제조 방법 및 포토마스크 조립체의 제조 방법
CN112285351A (zh) * 2019-07-22 2021-01-29 上海益诺思生物技术股份有限公司 一种抗IgE单抗的ELISA检测方法
WO2021046316A2 (en) * 2019-09-05 2021-03-11 Adverum Biotechnologies Anti-drug antibody assay
CN111171141A (zh) * 2020-01-20 2020-05-19 苏州药明康德新药开发有限公司 聚乙二醇在临床前安全性评价中的应用
CN111024958B (zh) * 2020-03-11 2020-06-23 同昕生物技术(北京)有限公司 用于检测单抗药物和抗单抗药物抗体的试剂及其应用
BR112022021039A2 (pt) * 2020-05-01 2022-12-06 Regeneron Pharma Ensaio de anticorpo neutralizante para proteínas terapêuticas
JP7478040B2 (ja) * 2020-06-25 2024-05-02 シスメックス株式会社 Aβペプチドの測定方法及びその方法に用いられる試薬組成物
US20230393144A1 (en) * 2020-10-14 2023-12-07 I-Mab Biopharma Us Limited Methods for mitigating interference by therapeutic anti-cd47 antibodies in pre-transfusion assays
JP7062803B1 (ja) * 2021-03-31 2022-05-06 積水メディカル株式会社 抗薬物抗体測定方法
WO2023110918A1 (en) 2021-12-14 2023-06-22 Cdr-Life Ag Dual mhc-targeting t cell engager
CN114047343B (zh) * 2022-01-13 2022-05-31 美迪西普亚医药科技(上海)有限公司 双耐受型抗IgE单抗药物的免疫原性分析试剂盒及其使用方法和应用
WO2024052517A2 (en) 2022-09-09 2024-03-14 Bayer Aktiengesellschaft Medical use of ccr8 antibodies and dosing schedule
WO2024056758A1 (en) 2022-09-14 2024-03-21 Cdr-Life Ag Mage-a4 peptide dual t cell engagers
WO2024064044A1 (en) * 2022-09-23 2024-03-28 Merck Sharp & Dohme Llc Neutralization antibody assay method
CN115561355B (zh) * 2022-09-26 2024-04-30 重庆迪纳利医药科技有限责任公司 羧肽酶g2的中和抗体检测方法以及基于lc-ms/ms的检测系统
CN116699147A (zh) * 2023-08-04 2023-09-05 军科正源(北京)药物研究有限责任公司 检测总IgE含量的方法以及相关试剂盒
CN117849327A (zh) * 2024-03-06 2024-04-09 军科正源(北京)药物研究有限责任公司 用于检测苏金单抗抗药性抗体的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006515A1 (en) * 1988-12-09 1990-06-14 Centocor, Inc. Anti-idiotopic immunometric assay
US5187065A (en) * 1989-12-22 1993-02-16 Schutzer Steven E Method and materials for detecting lyme disease
JP4902674B2 (ja) * 2006-03-09 2012-03-21 エフ.ホフマン−ラ ロシュ アーゲー 抗薬物抗体アッセイ法
CA2686206A1 (en) * 2007-05-07 2008-11-13 Wyeth Elimination of interference in immunoassays caused by anti-carbohydrate antibodies
US20110020840A1 (en) * 2008-01-15 2011-01-27 Gerrit Jan Wolbink Method and kits for detecting antibodies against therapeutic antibodies
JP2010078374A (ja) 2008-09-24 2010-04-08 Olympus Corp 抗赤血球抗体の検出方法
US7799532B2 (en) * 2008-11-12 2010-09-21 Hemopet Detection and measurement of thyroid hormone autoantibodies
RU2013142278A (ru) 2011-02-17 2015-03-27 Нестек С.А. ТЕСТЫ ДЛЯ ДЕТЕКЦИИ АУТОАНТИТЕЛ К АНТИ-TNFα ЛЕКАРСТВЕННЫМ СРЕДСТВАМ
RU2638812C2 (ru) * 2012-03-08 2017-12-15 Ф. Хоффманн-Ля Рош Аг Мультиплексный иммунохроматографический способ определения циркулирующих иммунокомплексов
MX363403B (es) * 2013-07-04 2019-03-22 Hoffmann La Roche Inmumoensayo con interferencia suprimida para la deteccion de anticuerpos anti-farmacos en muestras de suero.
PL3105592T3 (pl) 2014-02-11 2019-04-30 Genzyme Corp Testy do wykrywania obecności lub ilości przeciwciała antylekowego

Also Published As

Publication number Publication date
EP3105592A1 (en) 2016-12-21
DK3105592T3 (en) 2019-02-04
US20150226758A1 (en) 2015-08-13
US9759732B2 (en) 2017-09-12
EP3105592B1 (en) 2018-10-17
ES2705403T3 (es) 2019-03-25
EP3667321A1 (en) 2020-06-17
CN106164670A (zh) 2016-11-23
CN106164670B (zh) 2019-06-14
EP3667321B1 (en) 2022-07-27
US20220187327A1 (en) 2022-06-16
HUE041669T2 (hu) 2019-05-28
MX2016010413A (es) 2016-11-30
US11215623B2 (en) 2022-01-04
SG11201606291VA (en) 2016-08-30
MX2020009021A (es) 2020-10-12
EP4137816A1 (en) 2023-02-22
CA2939080A1 (en) 2015-08-20
AU2020264316A1 (en) 2020-11-26
LT3105592T (lt) 2019-01-25
AU2015217261A1 (en) 2016-09-08
EP3422001B1 (en) 2020-03-25
AU2015217261B2 (en) 2020-08-27
US20180088140A1 (en) 2018-03-29
RS58212B1 (sr) 2019-03-29
PL3105592T3 (pl) 2019-04-30
US11927596B2 (en) 2024-03-12
TR201900160T4 (tr) 2019-02-21
PT3105592T (pt) 2019-01-23
SG10201906750XA (en) 2019-09-27
CY1121341T1 (el) 2020-05-29
SI3105592T1 (sl) 2019-02-28
EP3422001A1 (en) 2019-01-02
WO2015123315A1 (en) 2015-08-20

Similar Documents

Publication Publication Date Title
HRP20190026T1 (hr) Testovi za određivanje prisutnosti ili količine protutijela protiv lijeka
ZA201900353B (en) Anti-pd-l1 antibodies
IL262295B1 (en) Antibodies against pd–l1
IL265396A (en) Methods and compositions for detecting analytes
IL250415A0 (en) Antibodies against pd-l1
HK1250045A1 (zh) 用於檢測抗cd3同二聚體的基於細胞的測定
GB201611840D0 (en) Alpha-synuclein detection assay
EP3212757A4 (en) Microfluidic device for cell-based assays
IL266857A (en) You will notice antibodies
IL254687A0 (en) A bio-sensor system for rapid identification of an analyte
EP3384035A4 (en) ASSAYS FOR DETECTION OF NEUTRALIZING ANTIBODIES OF VAA
SG11201702573VA (en) Non-destructive acoustic metrology for void detection
HK1257199A1 (zh) 用於檢測cd37的抗體和測定
GB201409516D0 (en) Immunoassay for compounds of the NBOMe family
GB201405856D0 (en) Functional antibody assay
EP3092005A4 (en) Antibodies against glioma biomarkers
GB201414216D0 (en) Device for measuring the volume of urine
IL263517A (en) Gamma-glutamyl-l-epsilon-lysine-specific monoclonal antibody for monitoring apoptosis
PL2927879T3 (pl) Sposób wykrywania użytkowania pojazdów, zależnego od odległości
GB201705328D0 (en) Microfluidic device for detection of analytes
GB201607560D0 (en) Immunodiagnostic assay
HK1258302A1 (zh) 用於測定fc區修飾的抗體的免疫測定法
GB201415206D0 (en) Device for measuring the volume of urine
FI20140052A (fi) Järjestelmä esineiden läsnäolon havainnoimiseksi